Despite the high costs of hip fracture, many governments provide limited support for
osteoporosis screening. We demonstrated that osteoporosis screening by dual-energy X-ray …

Objective To profile osteoporosis (OP) care in patients with rheumatoid arthritis (RA) over the
past decade. Methods Patients with RA or osteoarthritis (OA) were followed from 2003 …

In 1970, there were no drugs under study for osteoporosis. Estrogen was used, but little was
known about the correct dose for preventing bone loss. At that time, fractures were not even …

Context Prolonged bisphosphonate (BP) treatment for osteoporosis prevents hip and other
fractures but causes atypical femoral fractures (AFF). Objective To establish the relationship …

Bone histomorphometric endpoints in transilial biopsies may be associated with increased
risk of atypical femoral fracture (AFF) in patients with osteoporosis who take antiresorptives …

Osteoporosis and associated fractures remain a common and costly health problem. Public
fears about rare side effects of efficacious drug treatments for osteoporosis have contributed …

Internet search rates for “vitamin D” were explored using Google Trends. Search rates
increased from 2004 until 2010 and thereafter displayed a seasonal pattern peaking in late …

Atypical femoral fracture (AFF), which is a low energy fracture in the subtrochanteric or
diaphysis region of the femur, has multifactorial causes that span macro-to microscale …

Characteristics of patients starting oral bisphosphonate therapy changed over time,
reflecting trends in osteoporosis management (eg, new drugs to market), and general …

Exposure to oral corticosteroids (OCS) is associated with an increased risk of osteoporosis
and fragility fractures. Guidelines suggest bisphosphonate (BP) therapy as the first-line …